Difference between revisions of "Template:Adrenergics"
From Self-sufficiency
m (1 revision: Drug templates from wikipedia) |
m (1 revision: World Health Organization essential medicines) |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 13: | Line 13: | ||
| group2 = [[α2-adrenergic receptor|α<sub>2</sub>]] | | group2 = [[α2-adrenergic receptor|α<sub>2</sub>]] | ||
− | | list2 = '''Agonists''': [[(R)-3-Nitrobiphenyline]]{{•}} [[4-NEMD]]{{•}} [[6-Fluoronorepinephrine|6-FNE]]{{•}} [[Amitraz]]{{•}} [[Apraclonidine]]{{•}} [[Brimonidine]]{{•}} [[Clonidine]]{{•}} [[Detomidine]]{{•}} [[Dexmedetomidine]]{{•}} [[Dihydroergotamine]]{{•}} [[Dipivefrine]]{{•}} [[Dopamine]]{{•}} [[Ephedrine]]{{•}} [[Ergotamine]]{{•}} [[Epinephrine]] (Adrenaline){{•}} [[Esproquin]]{{•}} [[Etilefrine]]{{•}} [[Ethylnorepinephrine]]{{•}} [[Guanabenz]]{{•}} [[Guanfacine]]{{•}} [[Guanoxabenz]]{{•}} [[Levonordefrin]]{{•}} [[Lofexidine]]{{•}} [[Medetomidine]]{{•}} [[Methyldopa]]{{•}} [[Mivazerol]]{{•}} [[Naphazoline]]{{•}} [[Norepinephrine]] (Noradrenaline){{•}} [[Phenylpropanolamine]]{{•}} [[Piperoxan]]{{•}} [[Pseudoephedrine]]{{•}} [[Rilmenidine]]{{•}} [[Romifidine]]{{•}} [[Talipexole]]{{•}} [[Tetrahydrozoline]]{{•}} [[Tizanidine]]{{•}} [[Tolonidine]]{{•}} [[Urapidil]]{{•}} [[Xylazine]]{{•}} [[Xylometazoline]]<br/>'''Antagonists''': [[Pyrimidinylpiperazine|1-PP]]{{•}} [[Adimolol]]{{•}} [[Aptazapine]]{{•}} [[Atipamezole]]{{•}} [[BRL-44408]]{{•}} [[Buflomedil]]{{•}} [[Cirazoline]]{{•}} [[Efaroxan]]{{•}} [[Esmirtazapine]]{{•}} [[Fluparoxan]]{{•}} [[GYKI-12,743]]{{•}} [[GYKI-16,084]]{{•}} [[Idazoxan]]{{•}} [[Mianserin]]{{•}} [[Mirtazapine]]{{•}} [[MK-912]]{{•}} [[NAN-190]]{{•}} [[Olanzapine]]{{•}} [[Phentolamine]]{{•}} [[Phenoxybenzamine]]{{•}} [[Piperoxan]]{{•}} [[Piribedil]]{{•}} [[Rauwolscine]]{{•}} [[Rotigotine]]{{•}} [[SB-269,970]]{{•}} [[Setiptiline]]{{•}} [[Spiroxatrine]]{{•}} [[Sunepitron]]{{•}} [[Tolazoline]]{{•}} [[Yohimbine]]<br/><small>* Note that many [[atypical antipsychotic]]s and [[azapirone]]s like [[buspirone]] and [[gepirone]] (via metabolite [[Pyrimidinylpiperazine|1-PP]]) antagonize α<sub>2</sub>-adrenergic receptors as well.</small> | + | | list2 = '''Agonists''': [[(R)-3-Nitrobiphenyline]]{{•}} [[4-NEMD]]{{•}} [[6-Fluoronorepinephrine|6-FNE]]{{•}} [[Amitraz]]{{•}} [[Apraclonidine]]{{•}} [[Brimonidine]]{{•}} [[Clonidine]]{{•}} [[Detomidine]]{{•}} [[Dexmedetomidine]]{{•}} [[Dihydroergotamine]]{{•}} [[Dipivefrine]]{{•}} [[Dopamine]]{{•}} [[Ephedrine]]{{•}} [[Ergotamine]]{{•}} [[Epinephrine]] (Adrenaline){{•}} [[Esproquin]]{{•}} [[Etilefrine]]{{•}} [[Ethylnorepinephrine]]{{•}} [[Guanabenz]]{{•}} [[Guanfacine]]{{•}} [[Guanoxabenz]]{{•}} [[Levonordefrin]]{{•}} [[Lofexidine]]{{•}} [[Medetomidine]]{{•}} [[Methyldopa]]{{•}} [[Mivazerol]]{{•}} [[Naphazoline]]{{•}} [[Norepinephrine]] (Noradrenaline){{•}} [[Phenylpropanolamine]]{{•}} [[Piperoxan]]{{•}} [[Pseudoephedrine]]{{•}} [[Rilmenidine]]{{•}} [[Romifidine]]{{•}} [[Talipexole]]{{•}} [[Tetrahydrozoline]]{{•}} [[Tizanidine]]{{•}} [[Tolonidine]]{{•}} [[Urapidil]]{{•}} [[Xylazine]]{{•}} [[Xylometazoline]]<br/>'''Antagonists''': [[Pyrimidinylpiperazine|1-PP]]{{•}} [[Adimolol]]{{•}} [[Aptazapine]]{{•}} [[Atipamezole]]{{•}} [[BRL-44408]]{{•}} [[Buflomedil]]{{•}} [[Cirazoline]]{{•}} [[Efaroxan]]{{•}} [[Esmirtazapine]]{{•}} [[Fenmetozole]]{{•}} [[Fluparoxan]]{{•}} [[GYKI-12,743]]{{•}} [[GYKI-16,084]]{{•}} [[Idazoxan]]{{•}} [[Mianserin]]{{•}} [[Mirtazapine]]{{•}} [[MK-912]]{{•}} [[NAN-190]]{{•}} [[Olanzapine]]{{•}} [[Phentolamine]]{{•}} [[Phenoxybenzamine]]{{•}} [[Piperoxan]]{{•}} [[Piribedil]]{{•}} [[Rauwolscine]]{{•}} [[Rotigotine]]{{•}} [[SB-269,970]]{{•}} [[Setiptiline]]{{•}} [[Spiroxatrine]]{{•}} [[Sunepitron]]{{•}} [[Tolazoline]]{{•}} [[Yohimbine]]<br/><small>* Note that many [[atypical antipsychotic]]s and [[azapirone]]s like [[buspirone]] and [[gepirone]] (via metabolite [[Pyrimidinylpiperazine|1-PP]]) antagonize α<sub>2</sub>-adrenergic receptors as well.</small> |
| group3 = [[β-adrenergic receptor|β]] | | group3 = [[β-adrenergic receptor|β]] | ||
Line 25: | Line 25: | ||
| group1 = [[Norepinephrine transporter|NET]] | | group1 = [[Norepinephrine transporter|NET]] | ||
− | | list1 = ''Selective norepinephrine reuptake inhibitors'': [[Atomoxetine]] (Tomoxetine){{•}} [[Ciclazindol]]{{•}} [[Esreboxetine]]{{•}} [[Lortalamine]]{{•}} [[Mazindol]]{{•}} [[Nisoxetine]]{{•}} [[Reboxetine]]{{•}} [[Talopram]]{{•}} [[Talsupram]]{{•}} [[Tandamine]]{{•}} [[Viloxazine]]; ''Norepinephrine-dopamine reuptake inhibitors'': [[Amineptine]]{{•}} [[Bupropion]] (Amfebutamone){{•}} [[Fencamine]]{{•}} [[Fencamfamine]]{{•}} [[Lefetamine]]{{•}} [[Levophacetoperane]]{{•}} [[LR-5182]]{{•}} [[Manifaxine]]{{•}} [[Methylphenidate]]{{•}} [[Nomifensine]]{{•}} [[O-2172]]{{•}} [[Radafaxine]]; ''Serotonin-norepinephrine reuptake inhibitors'': [[Bicifadine]]{{•}} [[Desvenlafaxine]]{{•}} [[Duloxetine]]{{•}} [[Eclanamine]]{{•}} [[Levomilnacipran]]{{•}} [[Milnacipran]]{{•}} [[Sibutramine]]{{•}} [[Venlafaxine]]; ''Serotonin-norepinephrine-dopamine reuptake inhibitors'': [[Brasofensine]]{{•}} [[Diclofensine]]{{•}} [[DOV-102,677]]{{•}} [[DOV-21,947]]{{•}} [[DOV-216,303]]{{•}} [[JNJ-7925476]]{{•}} [[JZ-IV-10]]{{•}} [[Methylnaphthidate]]{{•}} [[Naphyrone]]{{•}} [[NS-2359]]{{•}} [[PRC200-SS]]{{•}} [[SEP-225,289]]{{•}} [[SEP-227,162]]{{•}} [[Tesofensine]]; ''Tricyclic antidepressants'': [[Amitriptyline]]{{•}} [[Butriptyline]]{{•}} [[Cianopramine]]{{•}} [[Clomipramine]]{{•}} [[Desipramine]]{{•}} [[Dosulepin]]{{•}} [[Doxepin]]{{•}} [[Imipramine]]{{•}} [[Lofepramine]]{{•}} [[Nortriptyline]]{{•}} [[Protriptyline]]{{•}} [[Trimipramine]]; ''Tetracyclic antidepressants'': [[Amoxapine]]{{•}} [[Maprotiline]]{{•}} [[Mianserin]]{{•}} [[Oxaprotiline]]{{•}} [[Setiptiline]]; ''Others'': [[Cocaine]]{{•}} [[CP-39,332]]{{•}} [[EXP-561]]{{•}} [[Fezolamine]]{{•}} [[Nefazodone]]{{•}} [[Nefopam]]{{•}} [[Pridefrine]]{{•}} [[Tapentadol]]{{•}} [[Tramadol]]{{•}} [[Ziprasidone]] | + | | list1 = ''Selective norepinephrine reuptake inhibitors'': [[Amedalin]]{{•}} [[Atomoxetine]] (Tomoxetine){{•}} [[Ciclazindol]]{{•}} [[Daledalin]]{{•}} [[Esreboxetine]]{{•}} [[Lortalamine]]{{•}} [[Mazindol]]{{•}} [[Nisoxetine]]{{•}} [[Reboxetine]]{{•}} [[Talopram]]{{•}} [[Talsupram]]{{•}} [[Tandamine]]{{•}} [[Viloxazine]]; ''Norepinephrine-dopamine reuptake inhibitors'': [[Amineptine]]{{•}} [[Bupropion]] (Amfebutamone){{•}} [[Fencamine]]{{•}} [[Fencamfamine]]{{•}} [[Lefetamine]]{{•}} [[Levophacetoperane]]{{•}} [[LR-5182]]{{•}} [[Manifaxine]]{{•}} [[Methylphenidate]]{{•}} [[Nomifensine]]{{•}} [[O-2172]]{{•}} [[Radafaxine]]; ''Serotonin-norepinephrine reuptake inhibitors'': [[Bicifadine]]{{•}} [[Desvenlafaxine]]{{•}} [[Duloxetine]]{{•}} [[Eclanamine]]{{•}} [[Levomilnacipran]]{{•}} [[Milnacipran]]{{•}} [[Sibutramine]]{{•}} [[Venlafaxine]]; ''Serotonin-norepinephrine-dopamine reuptake inhibitors'': [[Brasofensine]]{{•}} [[Diclofensine]]{{•}} [[DOV-102,677]]{{•}} [[DOV-21,947]]{{•}} [[DOV-216,303]]{{•}} [[JNJ-7925476]]{{•}} [[JZ-IV-10]]{{•}} [[Methylnaphthidate]]{{•}} [[Naphyrone]]{{•}} [[NS-2359]]{{•}} [[PRC200-SS]]{{•}} [[SEP-225,289]]{{•}} [[SEP-227,162]]{{•}} [[Tesofensine]]; ''Tricyclic antidepressants'': [[Amitriptyline]]{{•}} [[Butriptyline]]{{•}} [[Cianopramine]]{{•}} [[Clomipramine]]{{•}} [[Desipramine]]{{•}} [[Dosulepin]]{{•}} [[Doxepin]]{{•}} [[Imipramine]]{{•}} [[Lofepramine]]{{•}} [[Nortriptyline]]{{•}} [[Protriptyline]]{{•}} [[Trimipramine]]; ''Tetracyclic antidepressants'': [[Amoxapine]]{{•}} [[Maprotiline]]{{•}} [[Mianserin]]{{•}} [[Oxaprotiline]]{{•}} [[Setiptiline]]; ''Others'': [[Cocaine]]{{•}} [[CP-39,332]]{{•}} [[EXP-561]]{{•}} [[Fezolamine]]{{•}} [[Nefazodone]]{{•}} [[Nefopam]]{{•}} [[Pridefrine]]{{•}} [[Tapentadol]]{{•}} [[Tramadol]]{{•}} [[Ziprasidone]] |
| group2 = [[Vesicular monoamine transporter|VMAT]] | | group2 = [[Vesicular monoamine transporter|VMAT]] | ||
Line 90: | Line 90: | ||
}}<noinclude>[[Category:Drug templates]]</noinclude> | }}<noinclude>[[Category:Drug templates]]</noinclude> | ||
− |
Latest revision as of 15:53, 27 September 2010
Lua error in package.lua at line 80: module 'Module:Color contrast' not found.